Regentis Biomaterials shares soar after the company files to withdraw its Form F-1 and cancels the previously proposed May public equity offering.
https://finviz.com/stock?t=RGNT&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.